Enormous progress has been made on the epic journey towards implementation of lung cancer screening in Europe. A breakthrough for lung health has been achieved with the EU proposal for a Council recommendation on cancer screening. https://bit.ly/3J4O0Jb.

Advocacy Department European Respiratory Society Brussels Belgium

Chest Disease Celal Bayar University Faculty of Medicine Manisa Turkey

Ciberes Madrid Spain

Clinical Department for Respiratory Diseases Jordanovac University Hospital Centre Zagreb School of Medicine University of Zagreb Zagreb Croatia

Department of Diagnostic and Interventional Radiology University Hospital Heidelberg German Center of Lung Research Heidelberg Germany

Department of Genetics and Clinical Immunology National Institute of Tuberculosis and Lung Diseases Warsaw Poland

Department of Pneumology Lungenklinik Heckeshorn HELIOS Klinikum Emil von Behring Berlin Germany

Department of Public Health University of Copenhagen Copenhagen Denmark

Department of Pulmonary Medicine Clínica Universidad de Navarra Madrid Spain

Department of Radiology Mount Sinai Health System New York NY USA

Department of Respiratory Medicine 1st Faculty of Medicine Charles University Thomayer University Hospital Prague Czech Republic

Department of Respiratory Medicine and Allergy Karolinska University Hospital Stockholm Sweden

European Lung Foundation Sheffield UK

Hospital and University Center of Coimbra Pulmonology Service Coimbra Portugal

Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czech Republic

National Screening Centre Institute of Health Information and Statistics of the Czech Republic Prague Czech Republic

Queen Mary University of London London UK

These authors contributed equally

Unit of Integrative Metabolomics Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden

University Hospital Pulmonary Department Charles University Hradec Kralove Czech Republic

Zobrazit více v PubMed

Kauczor HU, Bonomo L, Gaga M, et al. . ESR/ERS white paper on lung cancer screening. Eur Respir J 2015; 46: 28–39. doi:10.1183/09031936.00033015 PubMed DOI PMC

European Commission . European Health Union: a new EU approach on cancer detection – screening more and screening better. https://ec.europa.eu/commission/presscorner/detail/en/ip_22_5562 Date last accessed: 5 October 2022. Date last updated: 20 September 2022.

European Respiratory Society, Czech Pneumological and Phthiseological Society, Czech Presidency of the Council of the European Union . Healthier Lungs, Healthier People: A Project For the EU. https://www.ersnet.org/events/healthy-lungs-project-for-the-eu/ Date last accessed: 5 October 2022. Date last updated: 2022.

European Commission . Factsheet – European Health Union: A new EU approach to cancer screening. https://ec.europa.eu/commission/presscorner/detail/en/fs_22_5586 Date last accessed: 5 October 2022. Date last updated: 20 September 2022.

Council of the European Union . Council Recommendation of 9 December 2022 on strengthening prevention through early detection: a new EU approach on cancer screening replacing Council Recommendation 2003/878/EC. Off J Eur Union 2022; C 173: 1–10.

European Commission , Directorate-General for Research and Innovation , Group of Chief Scientific Advisors . Cancer screening in the European Union. Publications Office of the European Union, 2022. https://data.europa.eu/doi/10.2777/867180 DOI

Science Advice for Policy by European Academies . Improving cancer screening in the European Union. https://sapea.info/topic/cancer-screening/ Date last accessed: 5 October 2022. Date last updated: 2 March 2022.

Van Meerbeeck JP, O'Dowd E, Ward B, et al. . Lung cancer screening: new perspective and challenges in Europe. Cancers (Basel) 2022; 14: 2343. doi:10.3390/cancers14092343 PubMed DOI PMC

European Commission . Europe's Beating Cancer Plan – Communication from the Commission to the European Parliament and the Council. https://health.ec.europa.eu/system/files/2022-02/eu_cancer-plan_en_0.pdf Date last accessed: 5 October 2022. Date last updated: 2022.

European Respiratory Society . Open letter – Increasing the early diagnosis of lung cancer in Europe: an essential milestone to tackle the biggest cancer killer. https://www.ersnet.org/wp-content/uploads/2021/10/Open-letter_ERS_Updated-13.10.2021.pdf Date last updated: 13 October 2021.

European Parliament . Report on strengthening Europe in the fight against cancer – towards a comprehensive and coordinated strategy (2020/2267(INI)). https://www.europarl.europa.eu/doceo/document/A-9-2022-0001_EN.pdf. Date last accessed: 5 October 2022. Date last updated: 2 February 2022.

Association Internationale de la Mutualité . AIM Cancer Screeing Recommendations. https://www.aim-mutual.org/wp-content/uploads/2022/06/ScreeningRecommendations_AIM_FINAL-1.pdf Date last accessed: 5 October 2022. Date last updated: 2022.

Association Internationale de la Mutualité . AIM calls on Member States to ensure that the final version of the Cancer Screening Recommendations reflects robust science. https://www.aim-mutual.org/wp-content/uploads/2022/09/PRCancerScreening_FINAL_29sept22-1.pdf 2022. Date last accessed: 5 October 2022. Date last updated: 2022.

National Lung Screening Trial Research Team . Lung cancer incidence and mortality with extended follow-up in the National Lung Screening Trial. J Thorac Oncol 2019; 14: 1732–1742. doi:10.1016/j.jtho.2019.05.044 PubMed DOI PMC

Doroudi M, Pinsky PF, Marcus PM. Lung cancer mortality in the lung screening study feasibility trial. JNCI Cancer Spectr 2018; 2: pky042. PubMed PMC

de Koning HJ, van der Aalst CM, de Jong PA, et al. . Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med 2020; 382: 503–513. doi:10.1056/NEJMoa1911793 PubMed DOI

Wille MM, Dirksen A, Ashraf H, et al. . Results of the randomized Danish lung cancer screening trial with focus on high-risk profiling. Am J Respir Crit Care Med 2016; 193: 542–551. doi:10.1164/rccm.201505-1040OC PubMed DOI

Blanchon T, Bréchot JM, Grenier PA, et al. . Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer 2007; 58: 50–58. doi:10.1016/j.lungcan.2007.05.009 PubMed DOI

Becker N, Motsch E, Trotter A, et al. . Lung cancer mortality reduction by LDCT screening – results from the randomized German LUSI trial. Int J Cancer 2020; 146: 1503–1513. doi:10.1002/ijc.32486 PubMed DOI

Pastorino U, Silva M, Sestini S, et al. . Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy. Ann Oncol 2019; 30: 1162–1169. doi:10.1093/annonc/mdz117 PubMed DOI PMC

Pastorino U, Boeri M, Sestini S, et al. . Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial. Ann Oncol 2022; 33: 395–405. doi:10.1016/j.annonc.2022.01.008 PubMed DOI

Infante M, Cavuto S, Lutman FR, et al. . Long-term follow-up results of the DANTE trial, a randomized study of lung cancer screening with spiral computed tomography. Am J Respir Crit Care Med 2015; 191: 1166–1175. doi:10.1164/rccm.201408-1475OC PubMed DOI

Paci E, Puliti D, Lopes Pegna A, et al. . Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial. Thorax 2017; 72: 825–831. doi:10.1136/thoraxjnl-2016-209825 PubMed DOI

Field JK, Vulkan D, Davies MPA, et al. . Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis. Lancet Reg Health Eur 2021; 10: 100179. doi:10.1016/j.lanepe.2021.100179 PubMed DOI PMC

Ministarstvo Zdravstva . National Program for Screening and Early Detection of Lung Cancer 2020–2024. https://zdravlje.gov.hr/UserDocsImages/2019%20Programi%20i%20projekti/NACIONALNI%20PROGRAM%20PREVENCIJE%20RAKA%20PLU%C4%86A.pdf Date last accessed: 5 October 2022. Date last updated: January 2020.

Institute of Health Information and Statistics of the Czech Republic . Czech Early Detection Programme for Lung Cancer. https://prevenceproplice.cz/en/ Date last accessed: 5 October 2022. Date last updated: 2022.

Polish Ministry of Health . Lung cancer screening program. https://www.gov.pl/web/zdrowie/program-badan-w-kierunku-wykrywania-raka-pluca Date last accessed: 5 October 2022. Date last updated: 2022.

Balata H, Ruparel M, O'Dowd E, et al. . Analysis of the baseline performance of five UK lung cancer screening programmes. Lung Cancer 2021; 161: 136–140. doi:10.1016/j.lungcan.2021.09.012 PubMed DOI

UK National Screening Committee . Adult Screening Programme Lung Cancer. https://view-health-screening-recommendations.service.gov.uk/lung-cancer/ Date last accessed: 29 September 2022.

Laisaar T. Thoracic surgery in Estonia. J Thorac Dis 2022; 14: 1719–1724. doi:10.21037/jtd-21-1146 PubMed DOI PMC

Vogel-Claussen J, Lasch F, Bollmann BA, et al. . Design and rationale of the HANSE study: a holistic German lung cancer screening trial using low-dose computed tomography. Rofo 2022; 194: 1333–1345. doi:10.1055/a-1853-8291 PubMed DOI PMC

Kerpel-Fronius A, Monostori Z, Kovacs G, et al. . Nationwide lung cancer screening with low-dose computed tomography: implementation and first results of the HUNCHEST screening program. Eur Radiol 2022; 32: 4457–4467. doi:10.1007/s00330-022-08589-7 PubMed DOI

Potter AL, Rosenstein AL, Kiang MV, et al. . Association of computed tomography screening with lung cancer stage shift and survival in the United States: quasi-experimental study. BMJ 2022; 376: e069008. PubMed PMC

Siegel RL, Miller KD, Fuchs HE, et al. . Cancer statistics, 2022. CA Cancer J Clin 2022; 72: 7–33. doi:10.3322/caac.21708 PubMed DOI

Flores R, Patel P, Alpert N, et al. . Association of stage shift and population mortality among patients with non-small cell lung cancer. JAMA Netw Open 2021; 4: e2137508. doi:10.1001/jamanetworkopen.2021.37508 PubMed DOI PMC

International Respiratory Coalition . Lung Facts. https://international-respiratory-coalition.org/lung-facts/ Date last accessed: 5 October 2022. Date last updated: 2022.

European Commission . EU Non-communicable diseases (NCDs) initiative: Guidance document. https://health.ec.europa.eu/publications/eu-non-communicable-diseases-ncds-initiative-guidance-document_en Date last accessed: 5 October 2022. Date last updated: 2022.

Kauczor HU, Baird AM, Blum TG, et al. . ESR/ERS statement paper on lung cancer screening. Eur Respir J 2020; 55: 3277–3294. doi:10.1183/13993003.00506-2019 PubMed DOI

EU4 Health Programme (EU4H) . Call for proposals to monitor and strengthen the implementation of innovative approaches to prostate, lung and gastric cancer screening at Union level (Topic ID: EU4H-2022-PJ-01). 2022. https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/eu4h-2022-pj-01

Strengthening the screening of Lung Cancer in Europe (SOLACE) . https://europeanlung.org/solace/.

Strengthening lung cancer screening in Europe: fostering participation, improving outcomes, and addressing health inequalities through collaborative initiatives in the SOLACE consortium